Cargando…

Haptoglobin treatment contributes to regulating nitric oxide signal and reduces oxidative stress in the penis: A preventive treatment for priapism in sickle cell disease

Background: In sickle cell disease (SCD), reduced bioavailability of endothelial NO and cGMP results in reduced expression of phosphodiesterase type 5 (PDE5), thus impairing the penile erection control mechanism and resulting in prolonged penile erection (priapism). In SCD, reduced NO bioavailabilit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pereira, Pamela da Silva, Pereira, Dalila Andrade, Calmasini, Fabiano Beraldi, Reis, Leonardo O., Brinkman, Nathan, Burnett, Arthur L., Costa, Fernando Ferreira, Silva, Fábio Henrique
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Physiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9514379/ https://www.ncbi.nlm.nih.gov/pubmed/36176769 http://dx.doi.org/10.3389/fphys.2022.961534

Ejemplares similares

Resveratrol-nitric oxide donor hybrid effect on priapism in sickle cell and nitric oxide-deficient mouse
por: Pinheiro, Andressa Kely, et al.
Publicado: (2022)

Hydroxyurea does not reverse functional alterations of the nitric oxide-cGMP pathway associated with priapism phenotype in corpus cavernosum from sickle cell mouse
por: Pereira, Dalila Andrade, et al.
Publicado: (2023)

Sympathetic Hyperactivity, Increased Tyrosine Hydroxylase and Exaggerated Corpus Cavernosum Relaxations Associated with Oxidative Stress Plays a Major Role in the Penis Dysfunction in Townes Sickle Cell Mouse
por: Silva, Fábio H., et al.
Publicado: (2016)

Sildenafil Citrate-Restored eNOS and PDE5 Regulation in Sickle Cell Mouse Penis Prevents Priapism Via Control of Oxidative/Nitrosative Stress
por: Bivalacqua, Trinity J., et al.
Publicado: (2013)

Prevalence of priapism in individuals with sickle cell disease and implications on male sexual function
por: Alvaia, Mateus Andrade, et al.
Publicado: (2020)

Nitric oxide status in sickle cell anemia
por: Gonçalves, Romélia Pinheiro
Publicado: (2012)

Incidence and predictors of priapism events in sickle cell anemia: a diary-based analysis
por: Idris, Ibrahim M., et al.
Publicado: (2022)

External validation of the priapism impact profile in a Jamaican cohort of patients with sickle cell disease
por: Morrison, Belinda F., et al.
Publicado: (2021)

Relation between haptoglobin polymorphism and oxidative stress status, lipid profile, and cardiovascular risk in sickle cell anemia patients
por: Kengne Fotsing, Christian Bernard, et al.
Publicado: (2022)

Nitric Oxide as a Central Molecule in Hypertension: Focus on the Vasorelaxant Activity of New Nitric Oxide Donors
por: da Silva, Gabriela Maria, et al.
Publicado: (2021)

Haptoglobin: an emerging candidate for phenotypic modulation of sickle cell anemia?()
por: Santos, Magnun Nueldo Nunes dos
Publicado: (2015)

Influence of Haptoglobin Polymorphism on Stroke in Sickle Cell Disease Patients
por: Edwards, Olivia, et al.
Publicado: (2022)

Our experience in the treatment of priapism
por: Vorobets, Dmytro, et al.
Publicado: (2011)

Haptoglobin Is Required to Prevent Oxidative Stress and Muscle Atrophy
por: Bertaggia, Enrico, et al.
Publicado: (2014)

Emergency Department Visits and Inpatient Admissions Associated with Priapism among Males with Sickle Cell Disease in the United States, 2006–2010
por: Dupervil, Brandi, et al.
Publicado: (2016)

Haptoglobin 1 allele predicts higher serum haptoglobin concentration and lower multiorgan failure risk in sickle cell disease
por: Ruiz, Maria A., et al.
Publicado: (2022)

Sickle cell trait and priapism: a case report and review of the literature
por: Birnbaum, Brian F, et al.
Publicado: (2008)

Priapism in Homozygous Sickle Cell Patients: Important Clinical and Laboratory Associations
por: Madu, Anazoeze Jude, et al.
Publicado: (2014)

Priapism in Sickle Cell Disease: An Evaluation of the Knowledge of an at Risk Population in Jamaica
por: Whyte, Nichelle, et al.
Publicado: (2021)

Interaction between the Haptoglobin 2 Phenotype and Diabetes Mellitus on Systolic Pulmonary Arterial Pressure and Nitric Oxide Bioavailability in Hemodialysis Patients
por: Dahan, Inbal, et al.
Publicado: (2015)

Haptoglobin and Sickle Cell Polymorphisms and Risk of Active Trachoma in Gambian Children
por: Savy, Mathilde, et al.
Publicado: (2010)

Correction: Emergency Department Visits and Inpatient Admissions Associated with Priapism among Males with Sickle Cell Disease in the United States, 2006–2010
por: Dupervil, Brandi M, et al.
Publicado: (2016)

Nitric Oxide in the Pathogenesis and Treatment of Tuberculosis
por: Jamaati, Hamidreza, et al.
Publicado: (2017)

Priapism in Sickle Cell Anemia: Emerging Mechanistic Understanding and Better Preventative Strategies
por: Crane, Genevieve M., et al.
Publicado: (2011)

Association between inflammatory molecules, nitric oxide metabolites and leg ulcers in individuals with sickle cell anemia
por: Belisário, André Rolim, et al.
Publicado: (2022)

Oxidative stress in sickle cell disease
por: Queiroz, Raphael Ferreira, et al.
Publicado: (2013)

Pharmacological characterization of the calcium influx pathways involved in nitric oxide production by endothelial cells
por: da Silva, Janyerson Dannys Pereira, et al.
Publicado: (2019)

Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction
por: Belcher, John D., et al.
Publicado: (2018)

Treatment of Priapism with Automated Red Cell Exchange and Hyperbaric Oxygen in an 11-year-old Patient with Sickle Cell Disease
por: Azık, Fatih Mehmet, et al.
Publicado: (2012)

Design, Synthesis, and Antisickling Investigation of a Nitric Oxide-Releasing Prodrug of 5HMF for the Treatment of Sickle Cell Disease
por: Alhashimi, Rana T., et al.
Publicado: (2022)

Design, Synthesis, and Investigation of Novel Nitric Oxide (NO)-Releasing Aromatic Aldehydes as Drug Candidates for the Treatment of Sickle Cell Disease
por: Huang, Boshi, et al.
Publicado: (2022)

Ruthenium Complex with Benznidazole and Nitric Oxide as a New Candidate for the Treatment of Chagas Disease
por: Sesti-Costa, Renata, et al.
Publicado: (2014)

Glibenclamide Increases Nitric Oxide Levels and Decreases Oxidative Stress in an In Vitro Model of Preeclampsia
por: Nunes, Priscila Rezeck, et al.
Publicado: (2022)

Chemotherapeutic Treatment of Priapism in Metastatic Rectal Cancer
por: Kitai, Y., et al.
Publicado: (2008)

Treatment of Priapism Secondary to Drugs for Erectile Dysfunction
por: Saffon Cuartas, José Pablo, et al.
Publicado: (2019)

P-093: PREVALENCE, KNOWLEDGE AND CLINICAL FEATURES OF PRIAPISM IN SICKLE CELL DISEASE IN SENEGAL
por: M., SECK, et al.
Publicado: (2022)

Anticancer potential of nitric oxide (NO) in neuroblastoma treatment
por: Gordon, Jenna L., et al.
Publicado: (2021)

The Application of Nitric Oxide for Ocular Hypertension Treatment
por: Han, Binze, et al.
Publicado: (2021)

Priapism in sickle cell disease: Associations between NOS3 and EDN1 genetic polymorphisms and laboratory biomarkers
por: Figueiredo, Camylla Vilas Boas, et al.
Publicado: (2021)

Low nitric oxide level is implicated in sickle cell disease and its complications in Ghana
por: Antwi-Boasiako, Charles, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_poe4vh521t3fkfk3pguccm43cm